Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2414 of 6351
-
Brain scans reveal how your diet may fuel obesity
Knowledge-focused CompletedThe purpose of this study is to use magnetic resonance imaging (MRI) to evaluate the human hypothalamus for signs of inflammation in response to specific diets. This research may lead to a better understanding of how poor nutritional quality may lead to obesity through effects on…
Sponsor: University of Washington • Aim: Knowledge-focused
Last updated Jul 19, 2026 00:00 UTC
-
New rapid tests aim to stop STIs in their tracks for pregnant women in zimbabwe
Diagnosis CompletedA prospective interventional study to evaluate a strategy of point-of-care testing for sexually transmitted infections including chlamydia, gonorrhoea, trichomoniasis, syphilis, and Hepatitis B with comprehensive case management including partner notification in antenatal setting…
Sponsor: London School of Hygiene and Tropical Medicine • Aim: Diagnosis
Last updated Jun 27, 2026 07:51 UTC
-
New taper strategy aims to free PMR patients from Long-Term steroids
Disease control OngoingPolymyalgia rheumatica (PMR) has an incidence of approximately 1000/10\^6 for persons more than 50 years. Treatment with prednisolone carries several significant adverse effects, and it is therefore essential to taper prednisolone as fast as possible. Systematic treatment strateg…
Sponsor: Aarhus University Hospital • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Can a diabetes drug stop oral cancer before it starts?
Prevention OngoingThis phase IIb trial tests whether metformin works in preventing oral cancer in patients with oral leukoplakia (white patches) or erythroplakia (red patches). Metformin is in a class of drugs called biguanides. Metformin helps to control the amount of glucose (sugar) in the blood…
Phase 2 • Sponsor: University of Arizona • Aim: Prevention
Last updated Sep 04, 2026 00:00 UTC
-
Xolair under the microscope: how well does it work for nasal polyps in real life?
Disease control CompletedThis study aims to evaluate the safety and effectiveness of Xolair® in patients with chronic rhinosinusitis with nasal polyps in routine clinical practice.
Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
Muscle fragments injected to fix fecal incontinence
Disease control Recruiting nowTo regenerate functional anal sphincter muscle using muscle fiber fragments that contain muscle precursor cells (MPCs)
Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
New combo attack on stomach cancer shows promise in small trial
Disease control CompletedThis study is an open-label, phase II study with a safety lead-in to assess the response rate of induction olaparib and stereotactic beam radiotherapy (SBRT) followed by combination olaparib/pembrolizumab in patients with metastatic gastric and GEJ cancers after at least one of t…
Phase 2 • Sponsor: University of Colorado, Denver • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
Texts and patches aim to help HIV patients kick the habit
Disease control Recruiting nowThe goal of this research study is to test how well an automated text messaging smoking treatment program helps smokers with HIV quit smoking.
Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Aug 15, 2026 00:00 UTC
-
Could a repurposed drug tame seizures in adult dravet patients?
Disease control Stopped earlyFull Title: Fenfluramine for the treatment of refractory Epilepsy in Adult Dravet patients Short Title: Fenfluramine for Adult Dravet patients Clinical Phase: Phase III Sample Size: A total of 15 participants will be included in the study. Study Population: Adult patients (18…
Phase 3 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Heart valve showdown: which measurement method wins for TAVR patients?
Knowledge-focused Recruiting nowData on valve performance following ViV-TAVR has usually been obtained with the use of Doppler-echocardiography. However, some reports have shown significant discordances in the evaluation of mean transvalvular gradient between echocardiography and catheterization, with an overes…
Sponsor: Institut universitaire de cardiologie et de pneumologie de Québec, University Laval • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC
-
Can the right walking workout boost stroke recovery?
Symptom relief Recruiting nowThe proposed research will evaluate the individual and combined effects of task-specificity and intensity of rehabilitation interventions on locomotor function, community mobility and quality of life in patients with subacute (1-6 months) post-stroke.
Sponsor: Indiana University • Aim: Symptom relief
Last updated Jun 27, 2026 12:01 UTC
-
Couples app aims to cut HIV and STI rates in male partners
Prevention CompletedThis couples-based, digital health intervention project is serostatus neutral and seeks to determine efficacy for: a) use and adherence to evidence-based HIV/STI prevention-care strategies; b) creation and adherence to a tailored prevention-care plan; c) creation and adherence to…
Sponsor: Florida International University • Aim: Prevention
Last updated Jun 26, 2026 17:56 UTC
-
New heart valve tested in global study to improve valve replacement outcomes
Disease control OngoingCollect real-world data on acute and long-term safety and performance of the MITRIS RESILIA Mitral Valve, Model 11400M, in subjects requiring replacement of their native or prosthetic mitral valve with or without concomitant procedures.
Sponsor: Edwards Lifesciences • Aim: Disease control
Last updated Jun 27, 2026 12:37 UTC
-
New scan could spot hidden amyloid in heart and organs
Diagnosis Recruiting nowThis is a single center prospective study evaluating 124I-evuzumitide in patients with systemic amyloidosis. The purpose of this study is to 1) Establish the diagnostic accuracy of 124I-evuzumitide in cardiac amyloidosis 2) Evaluate extracardiac uptake 3) identify and characteriz…
Phase 2 • Sponsor: Oregon Health and Science University • Aim: Diagnosis
Last updated Jun 27, 2026 12:07 UTC
-
New drug shows promise for rare liver disease itch
Symptom relief CompletedThe main aim of the study is to check if TAK-625 improves symptoms of Progressive Familial Intrahepatic Cholestasis (PFIC), side effect from the study treatment or TAK-625, and how much TAK-625 stays in their blood over time. This will help the study sponsor (Takeda) to work out …
Phase 3 • Sponsor: Takeda • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
Common drug may shield kidneys from chemo harm
Symptom relief CompletedHead and neck squamous cell carcinoma (HNSCC) encompasses a variety of tumors originating in the lip, oral cavity, hypopharynx, oropharynx, nasopharynx and larynx. It is the sixth most common malignancy worldwide accounting for approximately 6% of all cancer cases (Rettig and D'S…
Sponsor: Tanta University • Aim: Symptom relief
Last updated Jun 27, 2026 09:02 UTC
-
New device tackles tough leg artery blockages in japanese patients
Disease control CompletedThis is a prospective, single-arm, multi-center study designed to evaluate the safety and efficacy of the Orbital Atherectomy System (OAS) for the treatment of adult Japanese subjects with a de novo symptomatic calcified occlusive atherosclerotic lesion in the superficial femoral…
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Digital program aims to slash heart disease risk by lowering cholesterol
Disease control CompletedElevation in low density lipoprotein (LDL) cholesterol (LDL-C) is a causal risk factor for atherosclerotic established cardiovascular disease (ASCVD). Reduction of LDL-C with statins has been clearly demonstrated as a robust and cost-effective way of reducing the burden of ASCVD …
Sponsor: Hospital Israelita Albert Einstein • Aim: Disease control
Last updated Jun 27, 2026 12:07 UTC
-
HIV hiding spots revealed in treatment pause study
Knowledge-focused Recruiting nowBackground: Human immunodeficiency virus (HIV) infects CD4 T cells. There is no cure for HIV. People with HIV need to take daily medications called antiretroviral therapy (ART) to control their infection. ART stops HIV from infecting cells, but HIV does not go away. Some infecte…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Knowledge-focused
Last updated Sep 10, 2026 00:00 UTC
-
Gut bacteria may lift mood in bipolar depression
Symptom relief CompletedBipolar Disorder (BD) is highly incapacitating and associated with premature mortality. Depressive symptoms and episodes are the most frequent cause of disability in subjects with BD and over half of patients do not respond adequately to approved treatments for this condition, sh…
Sponsor: University of Sao Paulo • Aim: Symptom relief
Last updated Jun 27, 2026 12:32 UTC